Cubist Systematic Strategies’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.11M | Buy |
880,314
+68,707
| +8% | +$321K | 0.02% | 530 |
|
|
2025
Q1 | $4.46M | Buy |
+811,607
| New | +$4.46M | 0.03% | 464 |
|
|
2023
Q4 | – | Sell |
-95
| Closed | -$177 | – | 2733 |
|
|
2023
Q3 | $177 | Sell |
95
-15,009
| -99% | -$28K | ﹤0.01% | 1913 |
|
|
2023
Q2 | $39.6K | Buy |
+15,104
| New | +$39.6K | ﹤0.01% | 1930 |
|
|
2023
Q1 | – | Sell |
-7,968
| Closed | -$10.6K | – | 3315 |
|
|
2022
Q4 | $10.6K | Sell |
7,968
-6,678
| -46% | -$8.88K | ﹤0.01% | 3077 |
|
|
2022
Q3 | $23K | Sell |
14,646
-1,310
| -8% | -$2.06K | ﹤0.01% | 3425 |
|
|
2022
Q2 | $25K | Sell |
15,956
-199,290
| -93% | -$312K | ﹤0.01% | 3650 |
|
|
2022
Q1 | $551K | Sell |
215,246
-96,551
| -31% | -$247K | ﹤0.01% | 2457 |
|
|
2021
Q4 | $914K | Buy |
311,797
+294,251
| +1,677% | +$863K | 0.01% | 1982 |
|
|
2021
Q3 | $43K | Sell |
17,546
-29,684
| -63% | -$72.7K | ﹤0.01% | 2847 |
|
|
2021
Q2 | $192K | Sell |
47,230
-13,785
| -23% | -$56K | ﹤0.01% | 2579 |
|
|
2021
Q1 | $275K | Buy |
61,015
+15,618
| +34% | +$70.4K | ﹤0.01% | 2313 |
|
|
2020
Q4 | $223K | Buy |
+45,397
| New | +$223K | ﹤0.01% | 2186 |
|
|
2019
Q2 | – | Sell |
-25,693
| Closed | -$258K | – | 2601 |
|
|
2019
Q1 | $258K | Buy |
+25,693
| New | +$258K | 0.01% | 1608 |
|
|
2018
Q3 | – | Sell |
-645
| Closed | -$12K | – | 2092 |
|
|
2018
Q2 | $12K | Buy |
+645
| New | +$12K | ﹤0.01% | 1715 |
|